# NanoDiagnotic Technology I-Corps Training

> **NIH NIH R41** · NANODIAGNOSTIC TECHNOLOGY, LLC · 2022 · $55,000

## Abstract

Project Summary
Exposure to organophosphate (OP) pesticides, which can cause acute or chronic poisoning, is
the major environmental and occupational health problem across the world. There is a need for
a simple, rapid, cost-effective, and accurate biomonitoring tool for screening/assessing personal
exposure to OP pesticides. To address these issuers, NanoDiagnostic Technology, LLC (NDT)
proposed to develop an integrated smartphone/nanosensor platform serving as a new
biomonitoring tool for onsite, rapid, and accurate detection of personal exposure to OP
pesticides just using a minimal finger-prick blood sample and won an award of NIEHS STTR
phase I grant with the duration of June 1 2021 to May 31, 2022. Since starting the project, we
put great efforts on the technology development and made great progress and obtained very
promising results. At the same time, we actively worked on how to commercialize the
technology. We need to understand the needs of the market and where the customers are for
the technology. In September , 2021, the company formed a team and participated in a
six-week NSF I-Corps Fall 2021 training program at the UNC Charlotte Ventureprise and
conducted customer discovery through interviews. We still need more information on the
commercialization of our technology. We are very excited about this opportunity offered by the
NIH I-Corps Training program and eager to participate in this training program and acquire
more knowledge on how to translate our technology from a lab to the marketplace and gain
more information including but not limited to, further discovering customers, the need of market,
strategic partners, competitors, investors, building network in the field, etc. After completing this
training program, we will be able to establish our overall commercialization strategy and write a
strong proposal including both the technology and commercialization plan for STTR phase II
application.

## Key facts

- **NIH application ID:** 10541690
- **Project number:** 3R41ES032388-01A1S1
- **Recipient organization:** NANODIAGNOSTIC TECHNOLOGY, LLC
- **Principal Investigator:** Jun Wang
- **Activity code:** R41 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $55,000
- **Award type:** 3
- **Project period:** 2022-02-28 → 2022-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10541690

## Citation

> US National Institutes of Health, RePORTER application 10541690, NanoDiagnotic Technology I-Corps Training (3R41ES032388-01A1S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10541690. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*